 | Commercially manufactured Tamiflu for Oral Suspension (12 mg/mL) is the preferred product for pediatric and adult patients who have difficulty swallowing capsules. However, preparation of an oral suspension from the 75 mg Tamiflu Capsules, as described in the FDA-approved labeling resulting in a concentration of 15 mg/ml, may be necessary when the commercial suspension, Tamiflu for Oral Suspension (12 mg/ml), is not readily available in a timely manner because of an actual shortage of the product. |  |